Golimumab Subcutaneous and Risedronate Delayed-Release Tablets
Determining the interaction of Golimumab Subcutaneous and Risedronate Delayed-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: risedronate
Brand name: Actonel, Atelvia
Synonyms: Risedronate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Risedronate Sodium
- Golimumab Subcutaneous-Risedronate Tablets
- Golimumab Subcutaneous-Risperdal
- Golimumab Subcutaneous-Risperdal (Risperidone Oral Solution)
- Golimumab Subcutaneous-Risperdal (Risperidone Tablets)
- Golimumab Subcutaneous-Risperdal Consta
- Risedronate Delayed-Release Tablets-GoLYTELY
- Risedronate Delayed-Release Tablets-Gonadorelin
- Risedronate Delayed-Release Tablets-Gonadorelin Intravenous, Injection
- Risedronate Delayed-Release Tablets-Gonadotropin, Chorionic
- Risedronate Delayed-Release Tablets-Gonal-F
- Risedronate Delayed-Release Tablets-Gonal-f RFF